Eisai
Frank Lee, PhD, possesses extensive experience in biopharmaceutical development and biologics operations, currently serving as Sr. Director at Eisai US since October 2010. Previously held roles include Director of various departments at both Eisai Inc. and Morphotek Inc., and positions at Johnson & Johnson from April 2002 to October 2010, culminating as Associate Director in API Large Molecule Process Development. Early career experience includes leadership and engineering roles at Laureate Pharma and Regeneron Pharmaceuticals, alongside a postdoctoral fellowship at the University of Colorado at Boulder. Frank Lee earned a PhD in Chemical and Biochemical Engineering from UC Irvine and a BS in Chemical Engineering from National Cheng Kung University.
This person is not in any teams
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.